Trial in Progress: A Real-World Cohort Study Reporting Patient Profiles, Clinical Outcomes, and Unmet Medical Need of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in the Essen Center in Germany

被引：1
|
作者：
Versmold, Katharina
Raiser, Carina
Faghmous, Imi
Katz, Pablo
Shang, Aijing
Xu, Tao
Roth, Alexander
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140693
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 26 条
  • [1] Long-term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real-world setting
    Versmold, Katharina
    Alashkar, Ferras
    Raiser, Carina
    Ofori-Asenso, Richard
    Xu, Tao
    Liu, Yutong
    Katz, Pablo
    Shang, Aijing
    Roeth, Alexander
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (01) : 84 - 95
  • [2] Clinical Profile and Long-Term Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in a Real-World Setting: High Frequency of Anemia Despite Decreased Intravascular Hemolysis
    Versmold, Katharina
    Alashkar, Ferras
    Raiser, Carina
    Ofori-Asenso, Richard
    Xu, Tao
    Liu, Yutong
    Katz, Pablo
    Shang, Aijing
    Roeth, Alexander
    [J]. BLOOD, 2021, 138
  • [3] A Systematic Literature Review of Clinical and Economic Outcomes for Patients with Paroxysmal Nocturnal Hemoglobinuria in Clinical Trials and Real-World Settings
    Waheed, Anem
    Kaufhold, Samantha
    Liu, Che-Rung
    Lei, Jiali
    Nellesen, Dave
    Geevarghese, Anumaxine Lincy
    Yen, Glorian P.
    [J]. BLOOD, 2022, 140 : 11451 - 11452
  • [4] Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia
    Kulagin, Aleksandr
    Klimova, Olesya
    Rudakova, Tatiana
    Golubovskaya, Irina
    Ivanova, Maria
    Smirnova, Anna
    Lapina, Alexandra
    Bykova, Tatiana
    Babenko, Elena
    Popova, Marina
    Dobronravov, Vladimir
    Afanasyev, Boris
    [J]. BLOOD, 2018, 132
  • [5] Real-World Treatment Outcomes of Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Pegcetacoplan and Complement Protein 5 Inhibitors (C5i)
    Majerus, Elaine M.
    Mulherin, Brian
    Wilson, Koo
    Fishman, Jesse
    Mellor, Jennifer
    Earl, Lucy
    Roeth, Alexander
    [J]. BLOOD, 2023, 142
  • [6] COMMODORE Cohort: A Novel, Real-World, Noninterventional Cohort Study Using a Patient-Centered Approach to Evaluate the Safety and Effectiveness of C5 Inhibitors in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Shang, Aijing
    Faghmous, Imi
    Drozd, Dan
    Katz, Pablo
    [J]. BLOOD, 2020, 136
  • [7] Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
    Fishman, Jesse
    Kuranz, Seth
    Yeh, Michael M. M.
    Brzozowski, Kaylen
    Chen, Herman
    [J]. HEMATOLOGY REPORTS, 2023, 15 (02) : 266 - 282
  • [8] Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study
    Shammo, Jamile
    Gajra, Ajeet
    Patel, Yogesh
    Tomazos, Ioannis
    Kish, Jonathan
    Hill, Anita
    Sierra, J. Rafael
    Araten, David
    [J]. JOURNAL OF BLOOD MEDICINE, 2022, 13 : 425 - 437
  • [9] Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 2 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Not Previously Treated with Complement Inhibitors
    Kulasekararaj, Austin
    He, Guangsheng
    Munir, Talha
    Pu, Jeffrey
    Risitano, Antonio
    Roth, Alexander
    Sima, Camelia S.
    Appius, Anita
    Sostelly, Alexandre
    Sreckovic, Sasha
    Vignal, Charlotte
    Nishimura, Jun-Ichi
    [J]. BLOOD, 2020, 136
  • [10] Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 1 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Currently Treated with Complement Inhibitors
    Risitano, Antonio
    Roth, Alexander
    Kulasekararaj, Austin
    Pu, Jeffrey
    Nishimura, Jun-Ichi
    Wright, Lilyan
    Appius, Anita
    Sostelly, Alexandre
    Sreckovic, Sasha
    Vignal, Charlotte
    Munir, Talha
    [J]. BLOOD, 2020, 136
123